Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (June 12, 2007). doi:10.1152/physiolgenomics.00264.2006
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Tables and Figures
Right arrow All Versions of this Article:
31/2/216    most recent
00264.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fon Tacer, K.
Right arrow Articles by Rozman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fon Tacer, K.
Right arrow Articles by Rozman, D.
Submitted on December 4, 2006
Accepted on June 5, 2007

TNF-{alpha} INTERFERES WITH LIPID HOMEOSTASIS AND ACTIVATES ACUTE AND PRO-ATHEROGENIC PROCESSES

Klementina Fon Tacer1, Drago Kuzman2, Matej Seliskar1, Denis Pompon3, and Damjana Rozman1*

1 Center for Functional Genomic and Biochips, Institute of Biochemistry, University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia
2 Lek Pharmaceuticals, Ljubljana, Slovenia
3 LIPM, Centre de Genetique Moleculaire, CNRS, France

* To whom correspondence should be addressed. E-mail: damjana.rozman{at}mf.uni-lj.si.

The interaction between disrupted lipid homeostasis and immune response is implicated in the pathogenesis of several diseases, but the molecular bridges between the major players are still a matter of controversy. Our systemic study of the inflammatory cytokine tumor necrosis factor alpha (TNF-{alpha}) in the livers of mice exposed to 20 h-cytokine/fasting for the first time shows that TNF-{alpha} interferes with adaptation to fasting and activates harmful pro-atherogenic pathways, partially through the interaction with the insulin-Insig-Srebp (sterol regulatory element binding protein) signaling pathway. In addition to the increased expression of acute phase inflammatory genes, the most prominent alterations represent modified lipid homeostasis observed on the gene expression and metabolite levels. These include reduction of HDL-cholesterol, increase of LDL cholesterol, elevated expression of cholesterolgenic genes, accompanied by increase of potentially harmful pre-cholesterol metabolites and suppression of cholesterol elimination through bile acids, likely by Fxr-independent mechanisms. On the transcriptional level, a shift from fatty oxidation towards fatty acid synthesis is observed. The concept of TNF-{alpha} influence on the Srebp regulatory network, followed by downstream effects on sterol metabolism, is novel. Observed acute alterations in lipid metabolism are in agreement with chronic disturbances found in patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.